EGFR and small cell lung carcinoma: Targetable genomic alterations such as EGFR mutations and ALK/ROS1 translocations that are pathognomonic for LUAD have been reported in some LUSC patients and SCLC patients39,40, suggesting that the histology is not primarily determined by genomic features.